Citadel Advisors »

Bright Minds Biosciences shares owned by Citadel Advisors

Quarter-by-quarter ownership of Bright Minds Biosciences (DRUG) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Bright Minds Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Bright Minds Biosciences held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bright Minds Biosciences by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $393k 6.5k 60.66
2025-03-31 $248k 6.9k 36.07
2024-03-31 $21k 18k 1.20

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Strategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Call Option (UNH)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)

View all positions for Citadel Advisors

Top funds holding Bright Minds Biosciences

Henderson Group
Cormorant Asset Management
Vivo Capital
Commodore Capital
Perceptive Advisors
Adage Capital Partners GP
Braidwell
BlackRock
Sio Capital Management
Balyasny Asset Management
Morgan Stanley
Point72 Asset Management
Longwood Capital Partners
Millennium Management
Walleye Trading Advisors

View all funds holding Bright Minds Biosciences